{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:55:34Z","timestamp":1787648134154,"version":"build-2736575974"},"reference-count":26,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"unspecified","delay-in-days":71,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme Corp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001238","name":"Merck & Co., Inc., Kenilworth, NJ, USA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001238","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sanofi Pasteur, Inc"},{"name":"Swiftwater, PA, USA"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2020,12,1]]},"DOI":"10.1080\/14760584.2020.1873770","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T08:45:08Z","timestamp":1610959508000},"page":"1167-1175","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Budget impact analysis of introducing a non-reconstituted, hexavalent vaccine for pediatric immunization in the United Kingdom"],"prefix":"10.1080","volume":"19","author":[{"given":"D. A. R.","family":"Mathijssen","sequence":"first","affiliation":[{"name":"Pharmerit - an OPEN health company, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5339-6606","authenticated-orcid":false,"given":"M.","family":"Heisen","sequence":"additional","affiliation":[{"name":"Pharmerit - an OPEN health company, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F.","family":"Clark-Wright","sequence":"additional","affiliation":[{"name":"Sanofi Pasteur UK & Ireland, Reading, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6454-3368","authenticated-orcid":false,"given":"L. J.","family":"Wolfson","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc., Kenilworth, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Lu","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc., Kenilworth, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Carrol","sequence":"additional","affiliation":[{"name":"Sanofi Pasteur UK & Ireland, Reading, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.C.P.","family":"van Dijk","sequence":"additional","affiliation":[{"name":"Pharmerit - an OPEN health company, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. L.","family":"Klijn","sequence":"additional","affiliation":[{"name":"Pharmerit - an OPEN health company, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Alemayehu","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc., Kenilworth, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"key":"cit0001","unstructured":"World Health Organization (WHO). Immunization 2020 [cited 2020 Oct 08]. Available from: https:\/\/www.who.int\/topics\/immunization\/en\/"},{"key":"cit0002","unstructured":"World Health Organization (WHO). Country profiles, data, and statistics on immunization 2020 [cited 2020 Oct 08] 2020]. Available from: https:\/\/www.who.int\/immunization\/monitoring_surveillance\/en\/"},{"issue":"3","key":"cit0003","first-page":"139","volume":"22","author":"Lang S","year":"2014","journal-title":"Qual Primary Care"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.86.12.1812"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1111\/jorc.12050"},{"issue":"37","key":"cit0006","first-page":"49","volume":"26","author":"Adams D.","year":"2012","journal-title":"Nurs Stand"},{"key":"cit0007","unstructured":"European Medicines Agency. EMA\/859285\/2015 \u2013 Vaxelis; 2015."},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.06.030"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.03.088"},{"issue":"2","key":"cit0010","first-page":"E107","volume":"59","author":"Orsi A","year":"2018","journal-title":"J Prev Med Hyg"},{"key":"cit0011","volume-title":"Introduction to drug utilization research","author":"WHO International Working Group for Drug Statistics Methodology, WHO Collaborating Centre for Drug Statistics Methodology, WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services","year":"2003"},{"key":"cit0012","volume-title":"National population projections statistical bulletins. United Kingdom","author":"Office for National Statistics (ONS)","year":"2019"},{"key":"cit0013","volume-title":"Childhood Vaccination Coverage Statistics","author":"Screening & Immunizations Team (NHS Digital), COVER Team (Public Health England)","year":"2020"},{"key":"cit0014","volume-title":"Price indices, percentage changes and weights for the different measures of consumer price inflation","author":"Office for National Statistics (ONS)","year":"2020"},{"key":"cit0015","volume-title":"Unit costs of health and social care 2019. Unit costs of health and social care","author":"Curtis L","year":"2019"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2016.48"},{"key":"cit0017","unstructured":"Leeds City Council. Medical waste 2018 [cited 2018]. Available from: https:\/\/www.leeds.gov.uk\/residents\/bins-and-recycling\/medical-waste"},{"key":"cit0018","unstructured":"Sharps Compliance Inc. 28-Gallon medical professional sharps recover system with six 2-gallon sharps collection containers; 2018 [cited 2018]. Available from: https:\/\/www.sharpsinc.com\/store\/28-gallon-srs-2g-sharps-container"},{"key":"cit0019","unstructured":"OECD. Stat [Internet]. 2020 [cited 2020 Oct 13]. Available from: https:\/\/stats.oecd.org\/."},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-1542H"},{"key":"cit0021","volume-title":"The complete routine immunisation schedule. Immunisation information for health professionals and immunisation practitioners","author":"Public Health England","year":"2020"},{"key":"cit0022","unstructured":"European Medicines Agency. Hexyon, summary of product characteristics 2013 [Cited 2019 Jun]. Available from: https:\/\/www.ema.europa.eu\/documents\/product-information\/hexyon-epar-product-information_en.pdf"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1086\/651301"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.11.042"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182a14e57"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-003-0216-z"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2020.1873770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T10:03:29Z","timestamp":1625220209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2020.1873770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,1]]}},"alternative-id":["10.1080\/14760584.2020.1873770"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2020.1873770","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-08-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}